Welcome to: Rimonabant Information Source (rimonabant accomplia)

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Effective weight loss with Rimonabant
- rimonabant,
- where is rimonabant approved
- who will market rimonabant
- rimonabant structure
- buy rimonabant + links
- rimonabant a
- rimonabant accomplia
Rimonabant Pricelist
Please wait while we load the price list
Online availability of Acomplia If you want to get Acomplia online but are not sure if you will get it or not, read on. Most people can get this anti-obesity medicine without any problem. However, if you have certain medical conditions because of which Acomplia tablets becomes unsafe for you, you will not be able to get it online or offline. If you are obese i.e.your BMI is over 30, or are overweight and your BMI is between 27 and 30 and you are at risk of medical conditions related to weight or body fat, such as diabetes, high cholesterol, or hypertension, you can get Acomplia prescription online. If you meet any of the following criteria, you will not get Acomplia online: over 75 years of age decreased liver function decreased kidney function had a heart attack or stroke in the last six months history of depression or suicidal thoughts epilepsy allergy to rimonabant or any other ingredient of Acomplia Severely decreased liver and/or kidney function Uncontrolled serious psychiatric illness Major depressive illness People taking antidepressant medicines Pregnancy Breastfeeding Note: - If you are under treatment for any major depressive illness and are also taking antidepressants for it, do not take Acomplia anti-obesity medicine - Acomplia diet pills should not be taken by patients who have or had in past, suicidal thoughts or depressive disorder without consulting a doctor - Patients with uncontrolled psychiatric illness excluding depression should avoid taking Acomplia - If at anytime you experience any symptoms of depression, stop taking Acomplia immediately Why Acomplia is used as an anti-obesity medication? In a placebo-controlled, multi-centre clinical trial, 287 patients of both sexes, 18 to 65 years of age with a body mass index (BMI) of 29 to 41 were randomized to receive 5mg, 10mg, or 20mg of Acomplia rimonabant or placebo while on a slight calorie-controlled diet.
Potential obesity drug Acomplia (rimonabant) is set to be tested as a remedy for clogged arteries and heart disease. Already, the drug has been shown to help people lose weight and stop smoking (C&I 2004,18, 8). Now its developer, Sanofi-Aventis, reportedly plans to investigate its unexpected effects of increasing good cholesterol, in the hope that Acomplia will become the first drug to prevent metabolic syndrome. Related Results Challengers to AcompliaAcomplia.(Brief article)FDA committee rejects Acomplia due to suicide risksNew Innovative Medicine, ACOMPLIA (rimonabant) Now Available in Ireland. Sanofi wins EU approval to sell anti-obesity drug Acomplia Acomplia will be tested in obese smokers who have abnormalities in their blood fats, to see whether it can prevent or retard blocked arteries.
